Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines

Details for Australian Patent Application No. 2002358292 (hide)

Owner University of Central Florida

Inventors Daniell, Henry

Agent Callinan

Pub. Number AU-B-2002358292

PCT Number PCT/US02/41503

PCT Pub. Number WO2003/057834

Priority 60/393,651 03.07.02 US; 60/344,704 26.12.01 US; 60/400,816 02.08.02 US

Filing date 26 December 2002

Wipo publication date 24 July 2003

Acceptance publication date 18 December 2008

International Classifications

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

C07K 14/24 (2006.01) Peptides having more than 20 amino acids

C07K 14/28 (2006.01) Peptides having more than 20 amino acids

C07K 14/32 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/393,651 03.07.02 US; 60/344,704 26.12.01 US; 60/400,816 02.08.02 US

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2002358292

18 December 2008 Application Accepted

  Published as AU-B-2002358292

23 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002358293-DRUG RESPONSE MARKER IN BETA-1 ADRENERGIC RECEPTOR GENE

2002358291-ELECTROCHEMICAL EDGE AND BEVEL CLEANING PROCESS AND SYSTEM